B Cell Superantigen Immune Complex Tissue Inflammation
B Cell Superantigen Immune Complex Tissue Inflammation
批准号:
7340459
负责人:
ARNOLD I LEVINSON
金额:
$33.76万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-15 至 2009-10-31
关键词:
Antigen ReceptorsAntigen-Antibody ComplexAntigensArthus ReactionAutoimmune DiseasesB-LymphocytesBindingCellsComplementComplementarity Determining RegionsComplexCutaneousDepositionEventFamilyFramework RegionsFrequenciesGene FamilyGoalsHumanImmunoglobulin GImmunoglobulin MImmunoglobulin Variable RegionImmunoglobulinsIn VitroInbred BALB C MiceInfectious AgentInflammationInflammatoryInjuryLightLungLung InflammationMediatingMediator of activation proteinMicrobeModelingMolecularMouse StrainsMusNumbersOryctolagus cuniculusOutcomePathogenesisPathologyPeptostreptococcusPeripheralPeritonitisProcessPropertyProteinsReactionReportingResearch PersonnelSerumSuperantigensTNF geneTissuesTreesantigen bindingbasechemokineclinically relevanthuman diseaseinsightinterestmacrophagemast cellmembermicrobialmouse modelprogramsrespiratory
中文摘要
与常规抗原不同,B细胞超抗原(B细胞SAg)结合免疫球蛋白的Fab B区
(Ig)互补决定区以外的分子。这些非传统的抗原可以
与大量宿主的外周B细胞和血清免疫球蛋白结合
与整个可变区重链(VH)或可变区轻链(VL)基因的许多成员相互作用
家人例如,由厌氧菌株Peptostreptococcusmagnus分泌的蛋白质L与厌氧菌株Peptostreptococcusmagnus反应。
大多数人Vk 1+、Vk 3+和Vk 4 + Ig以及同源鼠Vk+ Ig的Fab。B细胞SAgs
与大量血清IgG结合强调了它们引起免疫复合物介导的组织免疫的潜力。
损伤在本申请中提出的研究的总体目标是阐明细胞和细胞内的蛋白质。
肺中B细胞SAg诱导的免疫复合物介导的炎症的分子发病机制。的
具体目标是确定由B细胞SAg,蛋白L,
1)证明免疫复合物组织损伤的组织病理学相关性,2)需要与
选择性Vk Ig和3)由参与常规免疫调节的细胞/促炎介质协调。
抗原/抗体复合物介导的组织损伤。这些目标将通过使用小鼠品系进行检查
通过基因操作来分离感兴趣的因子。由于迄今为止描述的大多数B细胞SAg
来自无处不在的微生物,这些研究的信息可能会提供深入了解
感染因子促进免疫复合物介导的免疫复合物介导的
风湿性和自身免疫性疾病。
英文摘要
B cell superantigens (B cell SAgs), unlike conventional antigens, bind to the Fab regions of immunoglobulin
(Ig) molecules outside their complementarity determining regions. These unconventional antigens can react
with a substantial amount of a host's peripheral B cells and serum immunoglobulins by virtue of their ability
to interact with many members of an entire variable region heavy (VH) or variable region light (VL)gene
family. For example, protein L, secreted by the anaerobic strain Peptostreptococcusmagnus, reacts with the
Fabs of most human Vk1+, Vk3+, and Vk4+ Igs and homologous murine Vk+ Igs. The ability of B cell SAgs
to bind to a large amount of serum IgG underscores their potential to cause imune complex-mediatedtissue
injury. The overall objective of the studies proposed in this application is to elucidate the cellular and
molecular pathogenesis of B cell SAg-induced immune complex-mediated inflammation in the lung. The
specific goals are to determine whether lung inflammation induced by the B cell SAg, protein L,
1) demonstrates histopathological correlates of immune complex tissue injury, 2) requires the interaction with
selective Vk Igs and 3) is orchestrated by cells/proinflammatory mediators involved in conventional
antigen/antibody complex-mediated tissue injury. These objectives will be examined by using mouse strains
manipulated genetically to isolate the factors of interest. Since most of the B cell SAgs described to date
are derived from ubiquitous microbes, information from these studies will likely provide insight into
mechanisms by which infectious agents contribute to the pathogenesis of immune complex-mediated
rheumatic and autoimmune disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
B Cell Superantigen Immune Complex Tissue Inflammation
-
批准号:7179280
-
项目类别:
-
资助金额:$34.36万
-
财政年份:2006
-
负责人:ARNOLD I LEVINSON
-
依托单位:
B Cell Superantigen Immune Complex Tissue Inflammation
-
批准号:7106258
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2006
-
负责人:ARNOLD I LEVINSON
-
依托单位:
Intrathymic Pathogenesis of Myasthenia Gravis
-
批准号:6603397
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2001
-
负责人:ARNOLD I LEVINSON
-
依托单位:
Intrathymic Pathogenesis of Myasthenia Gravis
-
批准号:6511608
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2001
-
负责人:ARNOLD I LEVINSON
-
依托单位:
Intrathymic Pathogenesis of Myasthenia Gravis
-
批准号:6362038
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2001
-
负责人:ARNOLD I LEVINSON
-
依托单位:
Intrathymic Pathogenesis of Myasthenia Gravis
-
批准号:6740884
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2001
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:2263621
-
项目类别:
-
资助金额:$22.74万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:2431131
-
项目类别:
-
资助金额:$23.65万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399628
-
项目类别:
-
资助金额:$16.31万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:2714436
-
项目类别:
-
资助金额:$24.6万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B-CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399624
-
项目类别:
-
资助金额:$20.18万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B-CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399629
-
项目类别:
-
资助金额:$19.94万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399623
-
项目类别:
-
资助金额:$15.76万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399627
-
项目类别:
-
资助金额:$17.19万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:2263619
-
项目类别:
-
资助金额:$21.87万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B-CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399631
-
项目类别:
-
资助金额:$22.55万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B-CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399630
-
项目类别:
-
资助金额:$21.61万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B-CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:2263617
-
项目类别:
-
资助金额:$23.28万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
THYMIC B CELL ACTIVATION IN MYASTHENIA GRAVIS
-
批准号:3399626
-
项目类别:
-
资助金额:$11.95万
-
财政年份:1983
-
负责人:ARNOLD I LEVINSON
-
依托单位:
TRAINING PROGRAM/RHEUMATIC DISEASES
-
批准号:2077777
-
项目类别:
-
资助金额:$10.47万
-
财政年份:1982
-
负责人:ARNOLD I LEVINSON
-
依托单位:
海外基金